K M Renault1,2, E M Carlsen3, S Hædersdal1,4, L Nilas1,5, N J Secher6, J Eugen-Olsen7, D Cortes3,5, S F Olsen8,9, T I Halldorsson8,10,11, K Nørgaard12. 1. Department of Obstetrics and Gynecology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark. 2. Obstetric Clinic, JMC, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. 3. Department of Pediatrics, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark. 4. Center for Diabetes Research, Copenhagen University Hospital Gentofte, Hellerup, Denmark. 5. Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 6. The Research Unit Women's and Children's Health, the Juliane Marie Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. 7. Clinical Research Centre, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark. 8. Centre for Fetal Programming, Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark. 9. Department of Nutrition, Harvard School of Public Health, Boston, MA, USA. 10. Faculty of Food Science and Nutrition, University of Iceland, Reykjavik, Iceland. 11. Unit for Nutrition Research, Landspitali University Hospital, Reykjavik, Iceland. 12. Department of Endocrinology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
Abstract
BACKGROUND:Offspring of obese mothers have increased risk of developing obesity and related short- and long-term disease. The cause is multifactorial and may partly be explained by the unfavorable intrauterine environment. Intervention during pregnancy leading to a healthier lifestyle among obese may alter this. OBJECTIVE: To assess the effect of lifestyle intervention on markers of maternal metabolism and inflammation in 'the TOP (Treatment of Obese Pregnant Women) study', a randomized controlled trial. METHODS: In the TOP-study 425 participants with body mass index ⩾30 kg/m2 were randomized to intervention with dietary advices and physical activity assessed by pedometer (PA+D), physical activity assessed by pedometer (PA) or control (C). Of 389 participants completing the study 376 had available blood samples. Serum was analyzed for insulin, c-peptide, lipid profile, leptin, high-sensitivity CRP (hsCRP) and Soluble urokinase Plasminogen Activator Receptor (suPAR), in week 18-20 and 28-30, and simultaneously a 2-h oral glucose-tolerance-test was performed. Diet was assessed in gestational week 11-14 and 36-37 using a validated 360-item Food Frequency Questionnaire. RESULTS:Median levels of hsCRP in gestational week 28-30 were lower in each of the intervention groups (8.3 mg/l in PA+D group, P=0.03; and 8.8 mg/l in PA group, P=0.02) versus the control group (11.5 mg/l). Obtaining 11 000 steps per day as aimed for resulted in a 21% lower hsCRP compared to non-compliant women. Women reporting high carbohydrate intake had around 30% higher hsCRP concentrations in late gestation than women reporting the lowest intake. There were no differences in lipid profile or any of the metabolic markers in gestational week 28-30 when comparing the intervention and control groups. CONCLUSIONS:Lifestyle intervention in obese women can reduce hsCRP representing a marker of inflammation during pregnancy. The effect may partly be mediated by more physical activity and partly by changes in intake of carbohydrates and the glycaemic load.
RCT Entities:
BACKGROUND: Offspring of obese mothers have increased risk of developing obesity and related short- and long-term disease. The cause is multifactorial and may partly be explained by the unfavorable intrauterine environment. Intervention during pregnancy leading to a healthier lifestyle among obese may alter this. OBJECTIVE: To assess the effect of lifestyle intervention on markers of maternal metabolism and inflammation in 'the TOP (Treatment of Obese Pregnant Women) study', a randomized controlled trial. METHODS: In the TOP-study 425 participants with body mass index ⩾30 kg/m2 were randomized to intervention with dietary advices and physical activity assessed by pedometer (PA+D), physical activity assessed by pedometer (PA) or control (C). Of 389 participants completing the study 376 had available blood samples. Serum was analyzed for insulin, c-peptide, lipid profile, leptin, high-sensitivity CRP (hsCRP) and Soluble urokinase Plasminogen Activator Receptor (suPAR), in week 18-20 and 28-30, and simultaneously a 2-h oral glucose-tolerance-test was performed. Diet was assessed in gestational week 11-14 and 36-37 using a validated 360-item Food Frequency Questionnaire. RESULTS: Median levels of hsCRP in gestational week 28-30 were lower in each of the intervention groups (8.3 mg/l in PA+D group, P=0.03; and 8.8 mg/l in PA group, P=0.02) versus the control group (11.5 mg/l). Obtaining 11 000 steps per day as aimed for resulted in a 21% lower hsCRP compared to non-compliant women. Women reporting high carbohydrate intake had around 30% higher hsCRP concentrations in late gestation than women reporting the lowest intake. There were no differences in lipid profile or any of the metabolic markers in gestational week 28-30 when comparing the intervention and control groups. CONCLUSIONS: Lifestyle intervention in obesewomen can reduce hsCRP representing a marker of inflammation during pregnancy. The effect may partly be mediated by more physical activity and partly by changes in intake of carbohydrates and the glycaemic load.
Authors: N Oostdam; M N M van Poppel; M G A J Wouters; E M W Eekhoff; D J Bekedam; W K H Kuchenbecker; H W P Quartero; M H B Heres; W van Mechelen Journal: BJOG Date: 2012-05-23 Impact factor: 6.531
Authors: Stig Lyngbæk; Thomas Sehestedt; Jacob L Marott; Tine W Hansen; Michael H Olsen; Ove Andersen; Allan Linneberg; Sten Madsbad; Steen B Haugaard; Jesper Eugen-Olsen; Jørgen Jeppesen Journal: Int J Cardiol Date: 2012-03-28 Impact factor: 4.164
Authors: Ahmad Esmaillzadeh; Masoud Kimiagar; Yadollah Mehrabi; Leila Azadbakht; Frank B Hu; Walter C Willett Journal: Am J Clin Nutr Date: 2006-12 Impact factor: 7.045
Authors: Kristina M Renault; Kirsten Nørgaard; Lisbeth Nilas; Emma M Carlsen; Dina Cortes; Ole Pryds; Niels J Secher Journal: Am J Obstet Gynecol Date: 2013-09-20 Impact factor: 8.661
Authors: Lucilla Poston; Ruth Bell; Helen Croker; Angela C Flynn; Keith M Godfrey; Louise Goff; Louise Hayes; Nina Khazaezadeh; Scott M Nelson; Eugene Oteng-Ntim; Dharmintra Pasupathy; Nashita Patel; Stephen C Robson; Jane Sandall; Thomas A B Sanders; Naveed Sattar; Paul T Seed; Jane Wardle; Melissa K Whitworth; Annette L Briley Journal: Lancet Diabetes Endocrinol Date: 2015-07-09 Impact factor: 32.069
Authors: Kristina M Renault; Emma M Carlsen; Kirsten Nørgaard; Lisbeth Nilas; Ole Pryds; Niels J Secher; Sjurdur F Olsen; Thorhallur I Halldorsson Journal: PLoS One Date: 2015-07-20 Impact factor: 3.240
Authors: Susan W Groth; I Diana Fernandez; Robert C Block; Sally W Thurston; Eunyoung Wong; Jessica Brunner; Nicole Mayo; Ntemena Kapula; Yang Yu; Ying Meng; Kuan-Lin Yeh; Carolyn W Kinkade; Loralei L Thornburg; Thomas G O'Connor; Emily S Barrett Journal: Res Nurs Health Date: 2021-05-16 Impact factor: 2.238
Authors: Nina Ferrari; Laura Schmitz; Nikola Schmidt; Esther Mahabir; Patricia Van de Vondel; Waltraut M Merz; Walter Lehmacher; Stephanie Stock; Konrad Brockmeier; Regina Ensenauer; Tanja Fehm; Christine Joisten Journal: BMC Sports Sci Med Rehabil Date: 2020-09-10
Authors: Valerie K Sullivan; Lawrence J Appel; Jesse C Seegmiller; Scott T McClure; Casey M Rebholz Journal: J Nutr Date: 2021-10-01 Impact factor: 4.687